Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

NYSE:CDRE - New York Stock Exchange, Inc. - US12763L1052 - Common Stock - Currency: USD

33.58  -1.37 (-3.92%)

After market: 33.58 0 (0%)

Fundamental Rating

5

Taking everything into account, CDRE scores 5 out of 10 in our fundamental rating. CDRE was compared to 66 industry peers in the Aerospace & Defense industry. CDRE has an average financial health and profitability rating. CDRE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CDRE was profitable.
In the past year CDRE had a positive cash flow from operations.
Of the past 5 years CDRE 4 years were profitable.
In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M 40M 60M

1.2 Ratios

CDRE's Return On Assets of 5.31% is fine compared to the rest of the industry. CDRE outperforms 65.63% of its industry peers.
CDRE's Return On Equity of 10.90% is fine compared to the rest of the industry. CDRE outperforms 67.19% of its industry peers.
CDRE has a Return On Invested Capital of 7.07%. This is in the better half of the industry: CDRE outperforms 64.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is above the industry average of 7.98%.
Industry RankSector Rank
ROA 5.31%
ROE 10.9%
ROIC 7.07%
ROA(3y)4.84%
ROA(5y)5.5%
ROE(3y)12.48%
ROE(5y)N/A
ROIC(3y)10.66%
ROIC(5y)11.77%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 200 300 400

1.3 Margins

CDRE's Profit Margin of 6.34% is fine compared to the rest of the industry. CDRE outperforms 62.50% of its industry peers.
CDRE's Profit Margin has declined in the last couple of years.
CDRE has a better Operating Margin (10.60%) than 70.31% of its industry peers.
In the last couple of years the Operating Margin of CDRE has declined.
CDRE's Gross Margin of 39.92% is amongst the best of the industry. CDRE outperforms 85.94% of its industry peers.
CDRE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.6%
PM (TTM) 6.34%
GM 39.92%
OM growth 3Y-3.98%
OM growth 5YN/A
PM growth 3Y-5.59%
PM growth 5YN/A
GM growth 3Y3.25%
GM growth 5YN/A
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 20 30 40

5

2. Health

2.1 Basic Checks

CDRE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CDRE has more shares outstanding
CDRE has a better debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 4.08 indicates that CDRE is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.08, CDRE is doing good in the industry, outperforming 67.19% of the companies in the same industry.
CDRE has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as CDRE would need 7.39 years to pay back of all of its debts.
The Debt to FCF ratio of CDRE (7.39) is better than 64.06% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that CDRE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, CDRE is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.39
Altman-Z 4.08
ROIC/WACC0.77
WACC9.13%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 3.01 indicates that CDRE has no problem at all paying its short term obligations.
CDRE's Current ratio of 3.01 is fine compared to the rest of the industry. CDRE outperforms 68.75% of its industry peers.
CDRE has a Quick Ratio of 1.96. This is a normal value and indicates that CDRE is financially healthy and should not expect problems in meeting its short term obligations.
CDRE has a Quick ratio of 1.96. This is in the better half of the industry: CDRE outperforms 73.44% of its industry peers.
Industry RankSector Rank
Current Ratio 3.01
Quick Ratio 1.96
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

5

3. Growth

3.1 Past

CDRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.70%.
CDRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.81% yearly.
CDRE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.20%.
CDRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)-11.7%
EPS 3Y-2.81%
EPS 5YN/A
EPS Q2Q%-68.97%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y6.05%
Revenue growth 5YN/A
Sales Q2Q%-12.55%

3.2 Future

The Earnings Per Share is expected to grow by 16.18% on average over the next years. This is quite good.
The Revenue is expected to grow by 11.87% on average over the next years. This is quite good.
EPS Next Y2.4%
EPS Next 2Y15.97%
EPS Next 3Y16.18%
EPS Next 5YN/A
Revenue Next Year17.26%
Revenue Next 2Y13.77%
Revenue Next 3Y11.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 40.46, which means the current valuation is very expensive for CDRE.
Compared to the rest of the industry, the Price/Earnings ratio of CDRE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CDRE is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 24.48, the valuation of CDRE can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 70.31% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (22.68), we can say CDRE is valued inline with the index average.
Industry RankSector Rank
PE 40.46
Fwd PE 24.48
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CDRE's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CDRE is valued a bit cheaper than 67.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.43
EV/EBITDA 21.01
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CDRE does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CDRE may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 16.18% in the coming years.
PEG (NY)16.86
PEG (5Y)N/A
EPS Next 2Y15.97%
EPS Next 3Y16.18%

4

5. Dividend

5.1 Amount

CDRE has a Yearly Dividend Yield of 1.09%.
CDRE's Dividend Yield is rather good when compared to the industry average which is at 1.44. CDRE pays more dividend than 85.94% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, CDRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

40.93% of the earnings are spent on dividend by CDRE. This is a bit on the high side, but may be sustainable.
DP40.93%
EPS Next 2Y15.97%
EPS Next 3Y16.18%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (2/21/2025, 8:06:45 PM)

After market: 33.58 0 (0%)

33.58

-1.37 (-3.92%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners67.22%
Inst Owner Change-93.54%
Ins Owners31.66%
Ins Owner Change-0.22%
Market Cap1.36B
Analysts83.08
Price Target44.54 (32.64%)
Short Float %7.39%
Short Ratio6.63
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend0.32
Dividend Growth(5Y)N/A
DP40.93%
Div Incr Years1
Div Non Decr Years3
Ex-Date01-31 2025-01-31 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.12%
Min EPS beat(2)13.16%
Max EPS beat(2)43.08%
EPS beat(4)3
Avg EPS beat(4)16.49%
Min EPS beat(4)-23.27%
Max EPS beat(4)43.08%
EPS beat(8)6
Avg EPS beat(8)20.15%
EPS beat(12)7
Avg EPS beat(12)12.8%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.73%
Min Revenue beat(2)-15.05%
Max Revenue beat(2)-0.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)5.6%
Revenue beat(8)5
Avg Revenue beat(8)0.09%
Revenue beat(12)8
Avg Revenue beat(12)0.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.16%
PT rev (3m)1.16%
EPS NQ rev (1m)-3.16%
EPS NQ rev (3m)-3.16%
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-2.32%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 40.46
Fwd PE 24.48
P/S 2.64
P/FCF 48.43
P/OCF 38.95
P/B 4.54
P/tB 33.83
EV/EBITDA 21.01
EPS(TTM)0.83
EY2.47%
EPS(NY)1.37
Fwd EY4.09%
FCF(TTM)0.69
FCFY2.06%
OCF(TTM)0.86
OCFY2.57%
SpS12.71
BVpS7.39
TBVpS0.99
PEG (NY)16.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 10.9%
ROCE 10.49%
ROIC 7.07%
ROICexc 8.6%
ROICexgc 21.86%
OM 10.6%
PM (TTM) 6.34%
GM 39.92%
FCFM 5.46%
ROA(3y)4.84%
ROA(5y)5.5%
ROE(3y)12.48%
ROE(5y)N/A
ROIC(3y)10.66%
ROIC(5y)11.77%
ROICexc(3y)13.17%
ROICexc(5y)13.34%
ROICexgc(3y)27.3%
ROICexgc(5y)28.01%
ROCE(3y)15.83%
ROCE(5y)17.47%
ROICexcg growth 3Y-4.81%
ROICexcg growth 5YN/A
ROICexc growth 3Y-2.5%
ROICexc growth 5YN/A
OM growth 3Y-3.98%
OM growth 5YN/A
PM growth 3Y-5.59%
PM growth 5YN/A
GM growth 3Y3.25%
GM growth 5YN/A
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 7.39
Debt/EBITDA 2.77
Cap/Depr 43.76%
Cap/Sales 1.33%
Interest Coverage 4.14
Cash Conversion 49.75%
Profit Quality 85.99%
Current Ratio 3.01
Quick Ratio 1.96
Altman-Z 4.08
F-Score4
WACC9.13%
ROIC/WACC0.77
Cap/Depr(3y)30.69%
Cap/Depr(5y)28.8%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.99%
Profit Quality(3y)396.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.7%
EPS 3Y-2.81%
EPS 5YN/A
EPS Q2Q%-68.97%
EPS Next Y2.4%
EPS Next 2Y15.97%
EPS Next 3Y16.18%
EPS Next 5YN/A
Revenue 1Y (TTM)7.2%
Revenue growth 3Y6.05%
Revenue growth 5YN/A
Sales Q2Q%-12.55%
Revenue Next Year17.26%
Revenue Next 2Y13.77%
Revenue Next 3Y11.87%
Revenue Next 5YN/A
EBIT growth 1Y-6.63%
EBIT growth 3Y1.83%
EBIT growth 5YN/A
EBIT Next Year85.49%
EBIT Next 3Y32.73%
EBIT Next 5YN/A
FCF growth 1Y-19.69%
FCF growth 3Y17.76%
FCF growth 5YN/A
OCF growth 1Y-9.29%
OCF growth 3Y17.25%
OCF growth 5YN/A